Both in Pharmaceuticals
GRI Bio vs Mustang Bio
Over the past year GRI returned −97.0% and MBIO returned −71.9%; their daily moves had a correlation of 0.14.
GRI −97.0% MBIO −71.9%Growth of $1, one year, split-adjusted
| Metric | GRI | MBIO |
|---|---|---|
| Price | $1.57 | $0.3925 |
| Market cap | $3.4M | $3.0M |
| Today | −3.38% | +9.00% |
| 1 month | −18.7% | −15.2% |
| 6 months | −28.0% | −47.0% |
| Year to date | −77.3% | −60.0% |
| 1 year | −97.1% | −73.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $10.9M | $15.2M |
| Dividend yield | — | — |
| Volatility (60d) | 134.4% | 50.4% |
| Short % of float | 3.0% | 1.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).